Latest Financials News

Telix Pharmaceuticals has met its upgraded FY 2025 revenue guidance with US$804 million, driven by strong growth in its Precision Medicine segment and the successful US launch of Gozellix. The company also advanced multiple clinical trials and announced a strategic collaboration with Varian to combine radiopharmaceuticals with radiation therapy.

Group 6 Metals has delivered a standout quarter with record tungsten production and sales, significantly reducing debt while advancing underground mining plans at its Dolphin Mine.

Duketon Mining’s December 2025 quarterly report reveals significant gold anomalies across multiple projects and updated nickel resource estimates, underpinning a robust exploration outlook supported by a strong cash position.

West Wits Mining has raised A$27.5 million through a firm equity placement, fully funding its Qala Shallows gold project to first production targeted for March 2026, while also advancing uranium exploration.

Finbar Group has achieved over 70% presales for its Palmyra West Apartments project, signalling strong market demand ahead of construction starting in March 2026.

PhosCo Ltd reports significant progress at its Gasaat Phosphate Project in Tunisia, backed by a €1 million EBRD grant and promising drilling outcomes at KM and SAB deposits. The company is well positioned amid rising global phosphate demand and tightening supply.

Venari Minerals has completed a successful drilling campaign at its Red Mountain Lithium Project, with assay results confirming significant lithium mineralisation and advancing towards a maiden resource estimate. The company also secured critical water rights, enhancing project development prospects.

Auris Minerals has secured $3.2 million to expand its geological team and accelerate exploration in Western Australia's Bryah Basin, following mixed assay results from its Morck Well gold prospects.

Atomo Diagnostics has locked in exclusive global rights to a novel liver function test that rapidly detects liver injury, expanding its footprint in point-of-care diagnostics. The test, delivered on Atomo’s Pascal platform, targets drug-induced liver injury and chronic liver conditions with significant commercial potential.

29Metals Limited has announced a fully underwritten $150 million entitlement offer to bolster liquidity, address operational disruptions at Golden Grove, and accelerate development projects including the Gossan Valley and Capricorn Copper restart.

29Metals delivered a robust December quarter at its Golden Grove mine with strong copper and zinc production, while Capricorn Copper remains suspended pending critical regulatory approvals. The company is progressing key growth projects and board changes as it navigates liquidity and operational challenges.

29Metals reported a strong December quarter with increased copper and zinc production at Golden Grove, cost efficiencies, and steady progress on key projects, while Capricorn Copper remains suspended pending regulatory approvals.